Ali Teimoori
Overview
Explore the profile of Ali Teimoori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
759
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shoushtari M, Salehi-Vaziri M, Kadkhodazadeh M, Teimoori A, Arashkia A, Roohvand F, et al.
Int Immunopharmacol
. 2025 Jan;
148:114032.
PMID: 39832457
Dengue virus (DENV) remains a significant public health threat in tropical and subtropical regions, with effective antiviral treatments and vaccines still not fully established despite extensive research. A critical aspect...
2.
Arab-Bafrani Z, Nikoubin-Boroujeni M, Ebrahimi S, Teimoori A, Heidari E, Mousavi E
Nucleosides Nucleotides Nucleic Acids
. 2024 Nov;
:1-13.
PMID: 39571172
Determination of the different short oligonucleotide features in the full genome of fatal and mild coronavirus strains can show the researchers how these viruses evolved and became virulent strains. To...
3.
Danyaei A, Ghanbarnasab-Behbahani R, Teimoori A, Neisi N, Chegeni N
Iran J Basic Med Sci
. 2024 Nov;
27(12):1566-1573.
PMID: 39539450
Objectives: Breast neoplasm is a malignancy that can have a poor prognosis. The PI3K/AKT signaling pathway is frequently activated in various tumor types, including breast cancer, leading to alterations in...
4.
Zangooie S, Ghanbari R, Jalilian F, Mahmoudvand S, Teimoori A
Antivir Ther
. 2024 Sep;
29(5):13596535241271589.
PMID: 39311585
Background: This in vitro study aimed to investigate the effect of several phenolic compounds, including doxorubicin, quercetin, and resveratrol, on HSV-1 infection. Methods: The cytotoxicity of the drugs was assessed...
5.
Sedighi I, Raeisi R, Amiri J, Shalchi Z, Karami M, Jalilian F, et al.
J Res Health Sci
. 2024 Jul;
24(2):e00614.
PMID: 39072550
Background: Investigating the prevalence of the coronavirus disease 2019 (COVID-19) infection in asymptomatic children who have been in close contact with symptomatic individuals is instrumental for refining public health approaches,...
6.
Panahi M, Teimoori A, Esmaeili S, Aminianfar H, Milani A, Hosseini S, et al.
Iran Biomed J
. 2024 Jul;
28(4):214-20.
PMID: 39044638
Background: Since the beginning of the SARS-CoV-2 pandemic, there have been mutations caused by new SARS-CoV-2 variants, such as Alpha, Beta, Gamma, Delta, and Omicron, recognized as the variants of...
7.
Ketabi K, Meshkat Z, Soleimanjahi H, Teimoori A, Tanzadepanah H, Bakhshi F
Iran J Microbiol
. 2023 Dec;
15(6):796-802.
PMID: 38156307
Background And Objectives: Group A (RVA) is the most important causative agent of acute diarrheal disease in pediatrics 5 years and below. This study aimed to determine the distribution of...
8.
Gilanipour A, Teimoori A, Arabzadeh S, Mollaie H, Mousavi E
BMC Res Notes
. 2023 Nov;
16(1):344.
PMID: 37993939
Background: The proper function of Pattern Recognition Receptors (PRRs) as a part of the host immune system can eliminate numerous pathogens from the body. However, some viruses can manipulate PRRs...
9.
Ketabi K, Soleimanjahi H, Teimoori A, Hatamluyi B, Rezayi M, Meshkat Z
Mikrochim Acta
. 2023 Jul;
190(8):293.
PMID: 37458847
A novel genosensor was developed for rotavirus specific cDNA sequence detection. The genosensor was comprised of hierarchical flower-like gold nanostructures, MXene, and polypyrrole (HFGNs/MXene/PPY) nanocomposite as a signal amplification tag,...
10.
Salimi-Jeda A, Esghaei M, Keyvani H, Bokharaei-Salim F, Teimoori A, Abdoli A
Heliyon
. 2023 Mar;
9(2):e12445.
PMID: 36937033
[This corrects the article DOI: 10.1016/j.heliyon.2022.e10483.].